Sign in
4

Changes in Ownership

GYRE THERAPEUTICS, INC. Filed Acc 0001209191-20-040377

Director acquired 2,129 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
DESOUZA ERROL B Director 2020-07-01 Grant or award +2,129 14,627 D
Loading xslF345X03/doc4.xml…